Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Specific gene expression signatures induced by the multiple oncogenic alterations that occur within the PTEN/PI3K/AKT pathway in lung cancer.

De Marco C, Laudanna C, Rinaldo N, Oliveira DM, Ravo M, Weisz A, Ceccarelli M, Caira E, Rizzuto A, Zoppoli P, Malanga D, Viglietto G.

PLoS One. 2017 Jun 29;12(6):e0178865. doi: 10.1371/journal.pone.0178865. eCollection 2017.

2.

Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways.

Wee P, Wang Z.

Cancers (Basel). 2017 May 17;9(5). pii: E52. doi: 10.3390/cancers9050052. Review.

3.

ErbB Proteins as Molecular Target of Dietary Phytochemicals in Malignant Diseases.

Filippi A, Ciolac OA, Ganea C, Mocanu MM.

J Oncol. 2017;2017:1532534. doi: 10.1155/2017/1532534. Epub 2017 Feb 13. Review.

4.

CDK4/6 or MAPK blockade enhances efficacy of EGFR inhibition in oesophageal squamous cell carcinoma.

Zhou J, Wu Z, Wong G, Pectasides E, Nagaraja A, Stachler M, Zhang H, Chen T, Zhang H, Liu JB, Xu X, Sicinska E, Sanchez-Vega F, Rustgi AK, Diehl JA, Wong KK, Bass AJ.

Nat Commun. 2017 Jan 6;8:13897. doi: 10.1038/ncomms13897.

5.

Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells.

Guerriero I, D'Angelo D, Pallante P, Santos M, Scrima M, Malanga D, De Marco C, Ravo M, Weisz A, Laudanna C, Ceccarelli M, Falco G, Rizzuto A, Viglietto G.

Oncotarget. 2017 Mar 21;8(12):19172-19191. doi: 10.18632/oncotarget.13432.

6.

Role of Akt signaling in resistance to DNA-targeted therapy.

Avan A, Narayan R, Giovannetti E, Peters GJ.

World J Clin Oncol. 2016 Oct 10;7(5):352-369. Review.

7.

Differential effects of peptidoglycan on colorectal tumors and intestinal tissue post-pelvic radiotherapy.

Li G, Wu A, Qi D, Cui F, Zeng Y, Xie F, Wu H, Gu Y, Chen Q, Zhang X.

Oncotarget. 2016 Nov 15;7(46):75685-75697. doi: 10.18632/oncotarget.12353.

8.

CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancer.

Xu H, Wu K, Tian Y, Liu Q, Han N, Yuan X, Zhang L, Wu GS, Wu K.

Int J Oncol. 2016 Oct;49(4):1343-50. doi: 10.3892/ijo.2016.3639. Epub 2016 Jul 29.

9.

Nonstructural 3 Protein of Hepatitis C Virus Modulates the Tribbles Homolog 3/Akt Signaling Pathway for Persistent Viral Infection.

Tran SC, Pham TM, Nguyen LN, Park EM, Lim YS, Hwang SB.

J Virol. 2016 Jul 27;90(16):7231-47. doi: 10.1128/JVI.00326-16. Print 2016 Aug 15.

10.

Squamous Cell Cancers: A Unified Perspective on Biology and Genetics.

Dotto GP, Rustgi AK.

Cancer Cell. 2016 May 9;29(5):622-37. doi: 10.1016/j.ccell.2016.04.004. Review.

11.

Comparative mRNA Expression of eEF1A Isoforms and a PI3K/Akt/mTOR Pathway in a Cellular Model of Parkinson's Disease.

Khwanraj K, Madlah S, Grataitong K, Dharmasaroja P.

Parkinsons Dis. 2016;2016:8716016. doi: 10.1155/2016/8716016. Epub 2016 Feb 14.

12.
13.

The pluripotency factor NANOG promotes the formation of squamous cell carcinomas.

Palla AR, Piazzolla D, Alcazar N, Cañamero M, Graña O, Gómez-López G, Dominguez O, Dueñas M, Paramio JM, Serrano M.

Sci Rep. 2015 May 19;5:10205. doi: 10.1038/srep10205.

14.

Dual HER2 blockade: preclinical and clinical data.

Patel TA, Dave B, Rodriguez AA, Chang JC, Perez EA, Colon-Otero G.

Breast Cancer Res. 2014 Aug 1;16(4):419. doi: 10.1186/s13058-014-0419-5. Review. Erratum in: Breast Cancer Res. 2014;16(6):468.

15.

Trastuzumab or lapatinib with standard chemotherapy for HER2-positive breast cancer: results from the GEICAM/2006-14 trial.

Alba E, Albanell J, de la Haba J, Barnadas A, Calvo L, Sánchez-Rovira P, Ramos M, Rojo F, Burgués O, Carrasco E, Caballero R, Porras I, Tibau A, Cámara MC, Lluch A.

Br J Cancer. 2014 Mar 4;110(5):1139-47. doi: 10.1038/bjc.2013.831. Epub 2014 Jan 23.

16.

Interferon-λ1 linked to a stabilized dimer of Fab potently enhances both antitumor and antiviral activities in targeted cells.

Liu D, Chang CH, Rossi EA, Cardillo TM, Goldenberg DM.

PLoS One. 2013 May 16;8(5):e63940. doi: 10.1371/journal.pone.0063940. Print 2013.

17.

Cell survival and metastasis regulation by Akt signaling in colorectal cancer.

Agarwal E, Brattain MG, Chowdhury S.

Cell Signal. 2013 Aug;25(8):1711-9. doi: 10.1016/j.cellsig.2013.03.025. Epub 2013 Apr 18. Review.

18.

YM155 induces EGFR suppression in pancreatic cancer cells.

Na YS, Yang SJ, Kim SM, Jung KA, Moon JH, Shin JS, Yoon DH, Hong YS, Ryu MH, Lee JL, Lee JS, Kim TW.

PLoS One. 2012;7(6):e38625. doi: 10.1371/journal.pone.0038625. Epub 2012 Jun 18.

19.

A novel classification of lung cancer into molecular subtypes.

West L, Vidwans SJ, Campbell NP, Shrager J, Simon GR, Bueno R, Dennis PA, Otterson GA, Salgia R.

PLoS One. 2012;7(2):e31906. doi: 10.1371/journal.pone.0031906. Epub 2012 Feb 21.

20.

Isolation and characterization of mouse and human esophageal epithelial cells in 3D organotypic culture.

Kalabis J, Wong GS, Vega ME, Natsuizaka M, Robertson ES, Herlyn M, Nakagawa H, Rustgi AK.

Nat Protoc. 2012 Jan 12;7(2):235-46. doi: 10.1038/nprot.2011.437.

Supplemental Content

Support Center